Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2013
06/25/2013US8470887 Urea foam
06/25/2013US8470886 Topical ibuprofen formulations
06/25/2013US8470885 Composition and method for treatment of diabetes
06/25/2013US8470883 Preservative system and composition based on glycinate and hydroxyethyl sulfonate salt combination
06/25/2013US8470882 Amino acid salts of prostaglandins
06/25/2013US8470880 Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
06/25/2013US8470879 Fatty acid inhibitors
06/25/2013US8470878 Heterocyclic sulfonamide derivatives
06/25/2013US8470876 Lipid composition for the treatment of skin problems in companion animals
06/25/2013US8470875 Use of parthenolide derivatives as antileukemic and cytotoxic agents
06/25/2013US8470874 Pharmaceutical compositions comprising cannabichromene type compounds
06/25/2013US8470873 Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
06/25/2013US8470872 Compounds with activity at estrogen receptors
06/25/2013US8470871 Ligands that modulate RAR receptors
06/25/2013US8470870 Solid forms of an anti-HIV phosphoindole compound
06/25/2013US8470869 Salts of perindopril
06/25/2013US8470868 Formulation for the prevention of cardiovascular disease
06/25/2013US8470866 Isoindolinone derivatives
06/25/2013US8470865 Methods and compositions for increasing the anaerobic working capacity in tissues
06/25/2013US8470864 Compositions and methods for the treatment of overactive bladder
06/25/2013US8470863 Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonists
06/25/2013US8470862 Treatment or prevention of hypotension and shock
06/25/2013US8470861 Mitochondria-targeted antioxidant prodrugs and methods of use
06/25/2013US8470860 Phenyl-sulfamates as aromatase inhibitors
06/25/2013US8470859 Iminopyridine derivative and use thereof
06/25/2013US8470858 Agave syrup extract having anticancer activity
06/25/2013US8470857 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
06/25/2013US8470856 Anthranilamide compounds, process for their production and pesticides containing them
06/25/2013US8470855 Dual-use peptidase inhibitors as prodrugs for a therapy of inflammatory and other diseases
06/25/2013US8470854 Lactam-containing compounds and derivatives thereof as factor XA inhibitors
06/25/2013US8470853 Transdermal methods and systems for the delivery of anti-migraine compounds
06/25/2013US8470852 Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
06/25/2013US8470851 Substituted acetylenic imidazo[1,2-A]pyridine compounds as kinase inhibitors
06/25/2013US8470850 Inhibitors of VEGF receptor and HGF receptor signalling
06/25/2013US8470849 7-azaindole derivatives as selective 11-β-hydroxysteroid dehydrogenase type 1 inhibitors
06/25/2013US8470848 Organic compounds
06/25/2013US8470847 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
06/25/2013US8470846 Remedy for psychoneurotic diseases
06/25/2013US8470845 Analgesic and methods of treating pain
06/25/2013US8470844 Imidazoacridinone derivative compounds and methods for their use
06/25/2013US8470843 Azacyclic compounds
06/25/2013US8470842 Hydrochloride salts of 8-[{1-(3,5-Bis-trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
06/25/2013US8470841 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
06/25/2013US8470838 Quinazolinones useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity; N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide monomethanesulfonate; treating breast cancer
06/25/2013US8470837 MAPK/ERK kinase inhibitors
06/25/2013US8470836 Dipeptidyl peptidase-IV inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent
06/25/2013US8470834 AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
06/25/2013US8470833 Hair growth and/or regrowth compositions
06/25/2013US8470831 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
06/25/2013US8470830 5-(heterocyclyl)alkyl-N-(arylsulfonyl)indole compounds and their use as 5-HT6 ligands
06/25/2013US8470829 Imidazolidine derivative and use thereof
06/25/2013US8470828 Anellated pyridine compounds
06/25/2013US8470827 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
06/25/2013US8470826 Episomal fusion gene
06/25/2013US8470825 Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP
06/25/2013US8470824 Substituted naphto[2,3-f]quinoxaline-7,12-diones and pharmaceutical utility thereof
06/25/2013US8470823 Saturated bicyclic heterocyclic derivatives as SMO antagonists
06/25/2013US8470822 Folate mimetics and folate-receptor binding conjugates thereof
06/25/2013US8470821 PDE4B inhibitors and uses therefor
06/25/2013US8470820 Nitrogen-containing heteroaryl derivatives
06/25/2013US8470819 Benzimidazole and aza-benzimidazole carboxamides
06/25/2013US8470818 Compounds and methods for kinase modulation, and indications therefor
06/25/2013US8470817 Compounds and methods for treatment of cancer
06/25/2013US8470816 Nitrogen-containing heterocyclic compound and use thereof
06/25/2013US8470815 Nitrofuran compounds for the treatment of cancer and angiogenesis
06/25/2013US8470814 Diazepinedione derivative
06/25/2013US8470813 Thiazoline and oxazoline derivatives and their methods of use
06/25/2013US8470812 Substituted benzo-pyrimido-tetrazolo-diazepine compounds
06/25/2013US8470811 Substituted heterocyclylbenzylpyrazoles and use thereof
06/25/2013US8470810 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
06/25/2013US8470809 Crystalline sodium salt of cephalosporin antibiotic
06/25/2013US8470808 Oxidant scavengers for treatment of type I diabetes or type II diabetes
06/25/2013US8470807 Antioxidant
06/25/2013US8470806 Perhexiline for treating chronic heart failure
06/25/2013US8470805 Processes for preparing piperazinium salts of KMUP and use thereof
06/25/2013US8470804 11a, 12-derivatives of tetracycline compounds
06/25/2013US8470803 Boron-containing small molecules
06/25/2013US8470801 Myocardial perfusion imaging methods and compositions
06/25/2013US8470800 Method of reducing intraocular pressure in humans
06/25/2013US8470798 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
06/25/2013US8470796 Treatment of cancer by inhibition of IGFBPs and clusterin
06/25/2013US8470795 Antisense modulation of kinesin-like 1 expression
06/25/2013US8470791 RNA antagonist compounds for the inhibition of Apo-B100 expression
06/25/2013US8470789 Method for inducing and accelerating cells
06/25/2013US8470788 Topical application of ivermectin for the treatment of dermatological conditions/afflictions
06/25/2013US8470787 Hydrates of erythromycin salts, preparation and use thereof
06/25/2013US8470786 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
06/25/2013US8470785 Method for treating ocular cancer
06/25/2013US8470782 Transglutaminase inhibitors and methods of use thereof
06/25/2013US8470781 Use of effectors of glutaminyl and glutamate cyclases
06/25/2013US8470776 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
06/25/2013US8470774 Deoxycorticosterone induced elastin production
06/25/2013US8470773 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
06/25/2013US8470529 Methine-substituted cyanine dye compounds
06/25/2013US8470381 Spinosyn antifouling compositions, methods of use thereof and articles protected from attachment of biofouling organisms
06/25/2013US8470371 Polymeric micellar clusters and their uses in formulating drugs
06/25/2013US8470370 Controlled release formulations
06/25/2013US8470369 Bone paste composition
06/25/2013US8470368 Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
06/25/2013US8470366 Nicotine containing soft gelatin pastilles